We pride ourselves to be the very first leading clinic to introduce the revolutionary dermal fillers - Ellanse from Holland into the UK, by Dr Ayham Al-Ayoubi in March 2010.

Ellanse developed by AQTIS Medica, is the first dermal filler which offers a safe unique Tunable Longevity specifically designed for the field of aesthetic medicine and surgery with the result lasting from 3-5 years.

Ellanse is made of Poly-caprolactone (PCl), is a well-known totally bioresorbable soft medical polymer. PCl is used in numerous CE-marked and Food and Drug Administration (FDA) approved commercial bloresorbable product applications for several decades world-wide and has demonstrated an excellent safety profile.

Ellanse Advantages:

• Unique Tunable Longevity options for personalized and tailored treatment.
• Immediate and Sustained Performance up to 5 years.
• Predictable Controlled and Tunable Total Bioresorbability with an excellent safety profile.
• Optimal Biocompatibility and Safety due to very smooth spherical-shaped microparicles.
• A soft silky smooth formulation in a ready-for-use syringe.
• Safe product components with a long safety history of the non cross-linked soft bioresorbable medical polymer Poly-caprolactone and the aqueous gel.
• Elimination of sensitivity testing due to a non-animal, non-bacterial and non-human derived product.
• Unique Elasticity and Optimum Viscosity provide the additional advantage of targeted placement.

Portfolio of Ellanse for sustained and cost-effective results

ELLANSE offers the maximum potential for modeling due to the combination of optimum viscosity, unique elasticity and uniform homogeneity. Hence, the ELLANSE Family can be used in a variety of beautifying indications:

• Correcting wrinkles and folds
• Volumizing
• Contouring
• Sculpting

The ELLANSE is an injectable implant, indicated for deep dermal and subdermal implantation. The nasolabial folds used in the clinical study are representative for deep and sub-dermal soft tissue augmentat ion of the facial area.

Unique Elasticity

With the unique elasticity and optimum viscosity, ELLANSE provides the additional advantage of targeted placement. Thereby allowing cost-effective correction of facial wrinkles and folds.

Mechanism of Tunable Longevity Technology

The excellent performance and saftey of the Ellanse is well grounded in its mode of action and specificaly tunable characteristics.

Safety of Ellanse

The technology of AQTIS Medical has been developed from a design and performance perspective to optimze the safety profile of the Ellanse. The unique totally smooth ans spherical shape of the Ellanse microspheres is the basis fror optimal biocompatibily. This as rough surfaces and irregular shaped microparticles have a greater propensity to induce adverse events and result in decreased collagen deposition.

The specifically designed microsphere characteristics provide a safe and long-lasting high quality scaffold for tissue infiltration.

Long-Term Safety

The ong-term safety and total bioresorption of Ellanse components through the normal metabolic pathways has been well documented by numerous scientific biocompatibility studies and literature research. For the PCL-microspheres this has additionally been demonstrated via radio-labeled bioresorption studies. Totally bioresorbable dermal fillers guarantee the absence of long-term side effects and give you the benefit of reversible results.

High satisfaction at 12 months

Patient satisfaction at 12 months evaluated on the basis of GAIS (Global Aesthetic Improvement Scale) for Ellanse was found to be 90%. Average physician evaluation shows improvement in 92% patients based on GAIS.

Patient confidence at 12 months

Ellanse treatments were rated to be EXCELLENT or GOOD by 97% patients on the scale of likelihood to return for repeat treatment at 12 months.

Frequently Asked Questions

What is the difference between ELLANSE and other dermal fillers?

The unique advantages of ELLANSE are Sustained Performance, Tunable Longevity and Total Bioresorbability.

What is the specific difference between ELLANSE and hyaluronic acid (HA) fillers?

The optimum combination of high viscosity and unique elasticity distinguishes it from the more fluid and short-lasting HA-fillers In addition, ELLANSE stimulates the generation of new collagen tissue unlike HA-fillers, which are volumizers.

Is a skin test required?

No. ELLANSE is a non-animal, non-bacterial and non-human derived product.

Are there any side effects?

Very few have been reported in the clinical trial. However, common and expected injection-related side effects like swelling, redness and bruising might occur.

Before and After Photos

By Dr Ayham Al-Ayoubi Before	By Dr Ayham Al-Ayoubi After

---

---

---

---